OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ginsenoside Rg1 protects against neuronal degeneration induced by chronic dexamethasone treatment by inhibiting NLRP-1 inflammasomes in mice
Yaodong Zhang, Wen Hu, Biqiong Zhang, et al.
International Journal of Molecular Medicine (2017) Vol. 40, Iss. 4, pp. 1134-1142
Open Access | Times Cited: 45
Yaodong Zhang, Wen Hu, Biqiong Zhang, et al.
International Journal of Molecular Medicine (2017) Vol. 40, Iss. 4, pp. 1134-1142
Open Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
Protective Effects and Target Network Analysis of Ginsenoside Rg1 in Cerebral Ischemia and Reperfusion Injury: A Comprehensive Overview of Experimental Studies
Weijie Xie, Ping Zhou, Yifan Sun, et al.
Cells (2018) Vol. 7, Iss. 12, pp. 270-270
Open Access | Times Cited: 160
Weijie Xie, Ping Zhou, Yifan Sun, et al.
Cells (2018) Vol. 7, Iss. 12, pp. 270-270
Open Access | Times Cited: 160
Mechanisms of Panax ginseng action as an antidepressant
Yang Jin, Ranji Cui, Lihong Zhao, et al.
Cell Proliferation (2019) Vol. 52, Iss. 6
Open Access | Times Cited: 97
Yang Jin, Ranji Cui, Lihong Zhao, et al.
Cell Proliferation (2019) Vol. 52, Iss. 6
Open Access | Times Cited: 97
Ginsenoside Rg1 prevent and treat inflammatory diseases: A review
Yan Gao, Juntong Li, Jin Wang, et al.
International Immunopharmacology (2020) Vol. 87, pp. 106805-106805
Closed Access | Times Cited: 79
Yan Gao, Juntong Li, Jin Wang, et al.
International Immunopharmacology (2020) Vol. 87, pp. 106805-106805
Closed Access | Times Cited: 79
New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer’s disease
Jiaojiao Wu, Yang Yu, Yan Wan, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113207-113207
Open Access | Times Cited: 68
Jiaojiao Wu, Yang Yu, Yan Wan, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113207-113207
Open Access | Times Cited: 68
Ginsenoside Rg1 in neurological diseases: From bench to bedside
Shaojie Yang, Jing-ji Wang, Ping Cheng, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 5, pp. 913-930
Open Access | Times Cited: 56
Shaojie Yang, Jing-ji Wang, Ping Cheng, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 5, pp. 913-930
Open Access | Times Cited: 56
Immunomodulatory, Anti-Inflammatory, and Anti-Cancer Properties of Ginseng: A Pharmacological Update
Jose Antonio Valdés-González, Marta Sánchez, Ignacio Moratilla-Rivera, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3863-3863
Open Access | Times Cited: 38
Jose Antonio Valdés-González, Marta Sánchez, Ignacio Moratilla-Rivera, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3863-3863
Open Access | Times Cited: 38
Roles of ginsenosides in inflammasome activation
Young‐Su Yi
Journal of Ginseng Research (2017) Vol. 43, Iss. 2, pp. 172-178
Open Access | Times Cited: 70
Young‐Su Yi
Journal of Ginseng Research (2017) Vol. 43, Iss. 2, pp. 172-178
Open Access | Times Cited: 70
Rg1 improves LPS-induced Parkinsonian symptoms in mice via inhibition of NF-κB signaling and modulation of M1/M2 polarization
Jiaqi Liu, Ming Zhao, Zhao Zhang, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 4, pp. 523-534
Open Access | Times Cited: 55
Jiaqi Liu, Ming Zhao, Zhao Zhang, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 4, pp. 523-534
Open Access | Times Cited: 55
New mechanisms of ginseng saponin-mediated anti-inflammatory action via targeting canonical inflammasome signaling pathways
Young‐Su Yi
Journal of Ethnopharmacology (2021) Vol. 278, pp. 114292-114292
Closed Access | Times Cited: 53
Young‐Su Yi
Journal of Ethnopharmacology (2021) Vol. 278, pp. 114292-114292
Closed Access | Times Cited: 53
Targeting NLRP3 Inflammasome in Translational Treatment of Nervous System Diseases: An Update
Qingying Yu, Tingting Zhao, Molin Liu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 44
Qingying Yu, Tingting Zhao, Molin Liu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 44
Potential benefits of ginseng against COVID-19 by targeting inflammasomes
Young‐Su Yi
Journal of Ginseng Research (2022) Vol. 46, Iss. 6, pp. 722-730
Open Access | Times Cited: 36
Young‐Su Yi
Journal of Ginseng Research (2022) Vol. 46, Iss. 6, pp. 722-730
Open Access | Times Cited: 36
Biopharmaceutical characters and bioavailability improving strategies of ginsenosides
Wenli Pan, Binli Xue, Chulei Yang, et al.
Fitoterapia (2018) Vol. 129, pp. 272-282
Closed Access | Times Cited: 59
Wenli Pan, Binli Xue, Chulei Yang, et al.
Fitoterapia (2018) Vol. 129, pp. 272-282
Closed Access | Times Cited: 59
Comparison of the Protective Effects of Ginsenosides Rb1 and Rg1 on Improving Cognitive Deficits in SAMP8 Mice Based on Anti-Neuroinflammation Mechanism
Yujie Yang, Shanshan Li, Hong Huang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 42
Yujie Yang, Shanshan Li, Hong Huang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 42
Ginsenoside Rg1 ameliorates glomerular fibrosis during kidney aging by inhibiting NOX4 and NLRP3 inflammasome activation in SAMP8 mice
Xiaoyan Shen, Xianan Dong, Yuli Han, et al.
International Immunopharmacology (2020) Vol. 82, pp. 106339-106339
Closed Access | Times Cited: 40
Xiaoyan Shen, Xianan Dong, Yuli Han, et al.
International Immunopharmacology (2020) Vol. 82, pp. 106339-106339
Closed Access | Times Cited: 40
Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer’s disease
Haiyong Liang, Peipei Zhang, Xile Zhang, et al.
Aging (2021) Vol. 13, Iss. 5, pp. 7549-7569
Open Access | Times Cited: 36
Haiyong Liang, Peipei Zhang, Xile Zhang, et al.
Aging (2021) Vol. 13, Iss. 5, pp. 7549-7569
Open Access | Times Cited: 36
Ginsenoside and Its Therapeutic Potential for Cognitive Impairment
Hui Feng, Xue Mei, Hao Deng, et al.
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1310-1310
Open Access | Times Cited: 27
Hui Feng, Xue Mei, Hao Deng, et al.
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1310-1310
Open Access | Times Cited: 27
The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
Yao Shen, Liyin Qian, Hu Luo, et al.
Brain Sciences (2022) Vol. 12, Iss. 8, pp. 1057-1057
Open Access | Times Cited: 23
Yao Shen, Liyin Qian, Hu Luo, et al.
Brain Sciences (2022) Vol. 12, Iss. 8, pp. 1057-1057
Open Access | Times Cited: 23
Ginsenoside Rg1 protects against H2O2‑induced neuronal damage due to inhibition of the NLRP1 inflammasome signalling pathway in hippocampal neurons in�vitro
Tanzhen Xu, Xiaoyan Shen, Lingling Sun, et al.
International Journal of Molecular Medicine (2018)
Open Access | Times Cited: 43
Tanzhen Xu, Xiaoyan Shen, Lingling Sun, et al.
International Journal of Molecular Medicine (2018)
Open Access | Times Cited: 43
NLRP1 inflammasome in neurodegenerative disorders: from pathology to therapies
Miqin Zhang, Long Yang, Zhuo-yao Li, et al.
Cytokine & Growth Factor Reviews (2024)
Closed Access | Times Cited: 4
Miqin Zhang, Long Yang, Zhuo-yao Li, et al.
Cytokine & Growth Factor Reviews (2024)
Closed Access | Times Cited: 4
Ginsenosides Rg1, Rb1 and rare ginsenosides: promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis
Mingchun Jiang, Jiaxin Chi, Yifan Qiao, et al.
Pharmacological Research (2025) Vol. 212, pp. 107578-107578
Open Access
Mingchun Jiang, Jiaxin Chi, Yifan Qiao, et al.
Pharmacological Research (2025) Vol. 212, pp. 107578-107578
Open Access
Pyroptosis; igniting neuropsychiatric disorders from mild depression to aging-related neurodegeneration
Kiavsh Hushmandi, Russel J. Reıter, Najma Farahani, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111325-111325
Closed Access
Kiavsh Hushmandi, Russel J. Reıter, Najma Farahani, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111325-111325
Closed Access
Ginsenoside 25-OCH3-PPD Promotes Activity of LXRs To Ameliorate P2X7R-Mediated NLRP3 Inflammasome in the Development of Hepatic Fibrosis
Xin Han, Jian Song, Li‐Hua Lian, et al.
Journal of Agricultural and Food Chemistry (2018) Vol. 66, Iss. 27, pp. 7023-7035
Closed Access | Times Cited: 38
Xin Han, Jian Song, Li‐Hua Lian, et al.
Journal of Agricultural and Food Chemistry (2018) Vol. 66, Iss. 27, pp. 7023-7035
Closed Access | Times Cited: 38
Active ginseng components in cognitive impairment: Therapeutic potential and prospects for delivery and clinical study
Md. Jakaria, Md. Ezazul Haque, Joon-Soo Kim, et al.
Oncotarget (2018) Vol. 9, Iss. 71, pp. 33601-33620
Open Access | Times Cited: 36
Md. Jakaria, Md. Ezazul Haque, Joon-Soo Kim, et al.
Oncotarget (2018) Vol. 9, Iss. 71, pp. 33601-33620
Open Access | Times Cited: 36
Exploring the Potential Therapeutic Approach Using Ginsenosides for the Management of Neurodegenerative Disorders
Manju, Navneeta Bharadvaja
Molecular Biotechnology (2023) Vol. 66, Iss. 7, pp. 1520-1536
Closed Access | Times Cited: 10
Manju, Navneeta Bharadvaja
Molecular Biotechnology (2023) Vol. 66, Iss. 7, pp. 1520-1536
Closed Access | Times Cited: 10
Nutraceutical Compounds Targeting Inflammasomes in Human Diseases
Beatriz Castejón‐Vega, Francesca Giampieri, José M. Álvarez‐Suarez
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4829-4829
Open Access | Times Cited: 21
Beatriz Castejón‐Vega, Francesca Giampieri, José M. Álvarez‐Suarez
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4829-4829
Open Access | Times Cited: 21
